Clinical Chemistry, Malmö
981 – 990 of 1293
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Genetic variation in Arabidopsis suecica and its parental species A-arenosa and A-thaliana
(
- Contribution to journal › Article
-
Mark
Structural requirements for the intracellular subunit polymerization of the complement inhibitor C4b-binding protein.
(
- Contribution to journal › Article
-
Mark
Structural requirements of anticoagulant protein S for its binding to the complement regulator c4b-binding protein
(
- Contribution to journal › Article
-
Mark
Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases I in plasma by immunoassay
(
- Contribution to journal › Article
-
Mark
Molecular basis of quantitative factor V deficiency associated with factor V R2 haplotype.
(
- Contribution to journal › Article
-
Mark
Approved IFCC reference method for the measurement of HbA1c in human blood.
(
- Contribution to journal › Article
-
Mark
Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.
(
- Contribution to journal › Article
-
Mark
Semenogelin I and II, the predominant human seminal plasma proteins, are also expressed in non-genital tissues.
(
- Contribution to journal › Article
-
Mark
Thrombin-mediated proteolysis of factor V resulting in gradual B-domain release and exposure of the factor Xa-binding site.
(
- Contribution to journal › Article
-
Mark
Sensitive and specific enzymatic assay for the determination of precursor forms of prostate-specific antigen after an activation step
(
- Contribution to journal › Article